These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 7852533

  • 1. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment.
    Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):659-66. PubMed ID: 7852533
    [Abstract] [Full Text] [Related]

  • 2. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [Abstract] [Full Text] [Related]

  • 3. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI, Bragato R, Scacchi M, Branzi G, Osculati G, Viarengo R, Leonetti G, Cavagnini F.
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [Abstract] [Full Text] [Related]

  • 4. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

  • 5. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A, Beshyah SA, Rutherford O, Spinks TJ, Mayet J, Kyd P, Anyaoku V, Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R, Johnston DG.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [Abstract] [Full Text] [Related]

  • 6. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [Abstract] [Full Text] [Related]

  • 7. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [Abstract] [Full Text] [Related]

  • 8. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [Abstract] [Full Text] [Related]

  • 9. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [Abstract] [Full Text] [Related]

  • 10. Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency.
    Cho GY, Jeong IK, Kim SH, Kim MK, Park WJ, Oh DJ, Yoo HJ.
    Am J Cardiol; 2007 Sep 15; 100(6):1035-9. PubMed ID: 17826393
    [Abstract] [Full Text] [Related]

  • 11. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
    Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G.
    J Clin Endocrinol Metab; 2005 Sep 15; 90(9):5146-55. PubMed ID: 15985481
    [Abstract] [Full Text] [Related]

  • 12. Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality.
    Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA.
    Br Heart J; 1992 Jan 15; 67(1):92-6. PubMed ID: 1739534
    [Abstract] [Full Text] [Related]

  • 13. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F, Fernandez T, Martinez T, Peñalva A, Peinó R, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1998 Dec 15; 83(12):4350-4. PubMed ID: 9851776
    [Abstract] [Full Text] [Related]

  • 14. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM, Atkinson AB, Ennis C, Hadden DR, McCance DR, Sheridan B, Bell PM.
    J Clin Endocrinol Metab; 2001 Nov 15; 86(11):5342-7. PubMed ID: 11701703
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular diastolic function abnormalities in hypopituitary patients with GH deficiency: evidence for a subclinical cardiomyopathy.
    Ozbey N, Sezgil A, Oflaz H, Umman B, Orhan Y, Sencer E, Molvalilar S.
    J Endocrinol Invest; 2002 Nov 15; 25(7):590-7. PubMed ID: 12150332
    [Abstract] [Full Text] [Related]

  • 16. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2000 Oct 15; 85(10):3693-9. PubMed ID: 11061526
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov 15; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2001 Apr 15; 86(4):1574-9. PubMed ID: 11297586
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A, Spinelli L, Cuocolo A, Spiezia S, Pivonello R, di Somma C, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2002 Jul 15; 87(7):3097-104. PubMed ID: 12107207
    [Abstract] [Full Text] [Related]

  • 20. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency.
    Shulman DI, Root AW, Diamond FB, Bercu BB, Martinez R, Boucek RJ.
    J Clin Endocrinol Metab; 2003 Sep 15; 88(9):4095-9. PubMed ID: 12970269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.